Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: A randomized trial
Edward D. Verrier, Stanton K. Shernan, Kenneth M. Taylor, Frans Van De Werf, Mark F. Newman, John C. Chen, Michel Carrier, Axel Haverich, Kevin J. Malloy, Peter X. Adams, Thomas G. Todaro, Christopher F. Mojcik, Scott A. Rollins, Jerrold H. Levy
Research output: Contribution to journal › Article › peer-review
185Scopus
citations
Fingerprint
Dive into the research topics of 'Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: A randomized trial'. Together they form a unique fingerprint.